लोड हो रहा है…
Outcomes with Biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) in Older Patients Treated for Rheumatoid Arthritis
BACKGROUND: Biological disease-modifying antirheumatic drugs (bDMARDs) are recommended for rheumatoid arthritis (RA), but older patients reportedly experience more adverse events (AEs) and show variable treatment response. The objective of this study was to evaluate AEs and effectiveness of bDMARDs...
| मुख्य लेखकों: | , , , |
|---|---|
| स्वरूप: | Online लेख मूलपाठ |
| भाषा: | English |
| प्रकाशित: |
Canadian Geriatrics Society
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259924/ https://www.ncbi.nlm.nih.gov/pubmed/32494334 http://dx.doi.org/10.5770/cgj.23.393 |